Skip to main content

Table 1 Incidence, clinical characteristics and in-hospital outcomes of patients hospitalized with infective endocarditis in Spain from 2001 to 2015 according to T2DM status

From: Infective endocarditis according to type 2 diabetes mellitus status: an observational study in Spain, 2001–2015

 

T2DM

2001–2003

2004–2006

2007–2009

2010–2012

2013–2015

Total

Trend

Number of endocarditis

Yes

345

486

603

962

1040

3436

< 0.001

No

2019

2128

2304

3165

3574

13,190

< 0.001

Incidence per 100,000 per year*

Yes

6.0

7.8

8.9

12.8

13.1

10.0

< 0.001

No

3.9

3.8

3.8

5.1

5.5

4.5

< 0.001

Age, mean (SD)*

Yes

68.7 (9.8)

69.2 (9.9)

70.4 (9.9)

71.6 (10.2)

71.8 (10.3)

70.8 (10.2)

< 0.001

No

66.2 (12.1)

66.0 (12.3)

67.4 (12.5)

69.0 (12.2)

69.4 (12.4)

67.9 (12.4)

< 0.001

Female sex, n (%)

Yes

130 (37.7)

193 (39.7)

233 (38.6)

348 (36.2)

336 (32.3)

1240 (36.1)

0.023

No

667 (33.0)

704 (33.1)

786 (34.1)

1037 (32.8)

1131 (31.7)

4325 (32.8)

0.393

Charlson Comorbidity Index, mean (SD)*

Yes

1.0 (0.8)

1.0 (0.8)

1.0 (0.8)

1.1 (0.8)

1.1 (0.8)

1.1 (0.8)

< 0.001

No

0.8 (0.8)

0.8 (0.8)

0.9 (0.8)

1.0 (0.8)

1.0 (0.8)

0.9 (0.8)

< 0.001

Prosthetic valve carriers, n (%)

Yes

27 (7.8)

41 (8.4)

57 (9.5)

106 (11.0)

102 (9.8)

333 (9.7)

0.375

No

170 (8.4)

191 (9.0)

205 (8.9)

294 (9.3)

360 (10.1)

1220 (9.3)

0.280

Previous mitral valve disease, n (%)*

Yes

99 (28.7)

122 (25.1)

156 (25.9)

271 (28.2)

264 (25.4)

912 (26.5)

0.478

No

540 (26.8)

616 (29.0)

681 (29.6)

1034 (32.7)

1100 (30.8)

3971 (30.1)

< 0.001

Previous aortic valve disease, n (%)*

Yes

75 (21.7)

114 (23.5)

149 (24.7)

251 (26.1)

280 (26.9)

869 (25.3)

0.280

No

511 (25.3)

602 (28.3)

673 (29.2)

972 (30.7)

1122 (31.4)

3880 (29.4)

< 0.001

Readmissions, n (%)*

Yes

58 (16.8)

91 (18.7)

116 (19.2)

199 (20.7)

223 (21.4)

687 (20.0)

0.338

No

300 (14.9)

314 (14.8)

354 (15.4)

526 (16.6)

597 (16.7)

2091 (15.9)

0.128

Length of hospital stay, mean (SD)

Yes

28.24 (20.9)

28.9 (21.4)

28.48 (20.4)

27.69 (21.0)

24.76 (18.9)

27.17 (20.4)

< 0.001

No

28.33 (22.6)

27.87 (21.8)

28.25 (22.4)

27.18 (22.4)

26.66 (21.4)

27.51 (22.1)

0.018

In-hospital mortality, n (%)

Yes

87 (25.2)

101 (20.8)

135 (22.4)

209 (21.7)

182 (17.5)

714 (20.8)

0.015

No

431 (21.4)

397 (18.7)

439 (19.1)

638 (20.2)

657 (18.4)

2562 (19.4)

0.053

Costs, mean (SD)*

Yes

9137.6 (5486)

12,380.7 (8116.2)

14,928.4 (8646.3)

13,507.4 (11,465.3)

13,744.5 (10,822.8)

13,230.4 (10,000.7)

< 0.001

No

10,171.7 (7450.2)

12,746.6 (8463.6)

16,366.4 (11,276.8)

16,588.5 (17,974.3)

14,759.3 (12,184.5)

14,452.0 (12,845.6)

< 0.001

  1. T2DM type 2 diabetes mellitus, SD standard deviation
  2. *Denotes a p value < 0.05 for the difference when comparing total values between patients with and without T2DM (namely, the results in the “TOTAL” column). Trends for incidence were assessed using multivariable Poisson regression models adjusted by age and sex